Free Trial
→ Prepare now for May 31 event (From Stansberry Research) (Ad)

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Written by MarketBeat Staff
May 4, 2023

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • Five stocks we like better than Enphase Energy.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Enphase Energy Right Now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover
A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.7514 of 5 stars		$49.04+0.5%N/A66.27Hold$68.87
Moderna (MRNA)
4.5307 of 5 stars		$27.99+6.1%N/A-3.02Hold$53.95
Zscaler (ZS)
3.642 of 5 stars		$251.95-0.2%N/A-1,007.80Moderate Buy$238.53
Verizon Communications (VZ)
4.731 of 5 stars		$44.21-0.2%6.13%10.68Moderate Buy$47.41
Intel (INTC)
3.0991 of 5 stars		$21.27-0.5%2.35%-4.86Reduce$21.67
PDD (PDD)
4.799 of 5 stars		$117.38-0.9%N/A11.46Moderate Buy$174.00
T-Mobile US (TMUS)
4.8156 of 5 stars		$241.21-1.2%1.46%24.94Moderate Buy$257.68
Activision Blizzard (ATVI)
0.7806 of 5 stars		$94.42flat1.05%34.59N/AN/A
Meta Platforms (META)
4.1811 of 5 stars		$637.10-0.5%0.33%26.63Moderate Buy$701.05
Tesla (TSLA)
4.3276 of 5 stars		$343.82+0.5%N/A168.54Hold$289.43
Align Technology (ALGN)
4.8089 of 5 stars		$182.58-1.2%N/A32.55Moderate Buy$241.25
Merck & Co., Inc. (MRK)
4.9977 of 5 stars		$77.92+0.9%4.16%11.58Moderate Buy$109.19
International Business Machines (IBM)
4.4513 of 5 stars		$266.76-0.6%2.52%41.62Moderate Buy$249.06
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
May 20, 2025

Magnificent 7 Stocks Shift Toward Stability and Selective Growth

After a fast rebound from correction territory, the Magnificent 7 stocks are no longer being treated the same by investors.

Watch Video

Related Videos

5 Blowout Earnings Winners That Could Soar Even Higher
Markets in Rally Mode: Will Earnings Keep It Going?
Buy the Fear: 3 Down Stocks That Could 10x Your Profits

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines